ClinicalTrials.Veeva

Menu

The Effectiveness of Breathing Therapy in Patients With Schizophrenia

A

Ataturk University

Status

Completed

Conditions

Breathing Therapy

Treatments

Other: Session 2: Recognizing the Illness
Other: Session 7: Relaxation
Other: Session 8: Evaluation
Other: Session 3: Treatment Evaluation
Other: Session 4: What is anger?
Other: Session 6: What is relaxation?
Other: Session 1: Preparation Session
Other: Session 5: Communication

Study type

Interventional

Funder types

Other

Identifiers

NCT07150507
MCENGİZ6

Details and patient eligibility

About

This study aimed to determine the effects of breathing therapies on sleep disturbances and fatigue in patients with schizophrenia.The study will be conducted at a CMHC in Ağrı province between May and August 2021. At the CMHC, community-based mental health services are provided to patients with severe mental disorders (schizophrenia, bipolar disorder) who are in remission as assessed by a psychiatrist. The study is planned to be conducted with patients who meet the study criteria, without using a sample selection method. Patients over the age of 18 registered with CMHC and followed with a diagnosis of schizophrenia were contacted by phone and invited to CMHC. The study was conducted with patients who met the inclusion criteria and agreed to participate. Data will be collected using the Descriptive Characteristics Form, the DSM-5 Sleep Disorder Scale, and the Brief Fatigue Inventory. The experimental group received eight sessions of respiratory therapy.The control group received no intervention. The study sample size was calculated using the GPower computer program. A power analysis performed at α=0.05 revealed an effect size of 150.153 (d=0.8), providing 90% power. Therefore, it was calculated that a minimum of 68 patients should be included in the sample.

Full description

Study data were collected by the researcher through face-to-face interviews. The study included individuals diagnosed with schizophrenia who met the inclusion criteria (registration in a CMHC, having a diagnosis of schizophrenia, willingness to participate in the study, and openness to communication and collaboration). Pre-test measurement instruments were administered to the participants. The experimental group received eight sessions of respiratory therapy. The control group received no intervention. Post-test data were collected following the training sessions.

Enrollment

68 patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Being registered with a CMHC
  • Being diagnosed with schizophrenia
  • Being between the ages of 18 and 60
  • Being willing to participate in the study
  • Being open to communication and cooperation
  • Being in remission

Exclusion criteria

  • Not being open to communication and cooperation

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

68 participants in 8 patient groups

Session 1: Preparatory Session
Experimental group
Description:
\*Meeting the patients \*Introducing the content of psychoeducation \*Emphasizing the importance of regular and timely attendance at training \*Determining training dates \*Sharing individuals' experiences and expectations
Treatment:
Other: Session 1: Preparation Session
Session 2: Recognizing the Illness
Experimental group
Description:
\*What is schizophrenia? \*What are its symptoms? \*What does treatment involve?
Treatment:
Other: Session 2: Recognizing the Illness
Session 3: Evaluating Treatment
Experimental group
Description:
\*Considerations regarding medication use \*Side effects of medication use \*Exacerbations in schizophrenia \*Premonitory symptoms.
Treatment:
Other: Session 3: Treatment Evaluation
Session 4: *What is anger?
Experimental group
Description:
\*What are the symptoms of anger? \*What are the methods for coping with anger?
Treatment:
Other: Session 4: What is anger?
Session 5: Communication *What is communication?
Experimental group
Description:
\*The importance of communication. \*Fundamentals of communication, self-language practice \*Ways to prevent communication difficulties.
Treatment:
Other: Session 5: Communication
Session 6: What is relaxation?
Experimental group
Description:
What is progressive relaxation. Relaxation CD introduction
Treatment:
Other: Session 6: What is relaxation?
Session 7: Relaxation
Experimental group
Description:
Performing the relaxation CD with patients
Treatment:
Other: Session 7: Relaxation
Session 8: Evaluation
Experimental group
Description:
\*Reinforcement of what has been learned. \*Evaluation of the program. \*Receiving feedback
Treatment:
Other: Session 8: Evaluation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems